171 related articles for article (PubMed ID: 32483388)
1. STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapy.
Arwert EN; Milford EL; Rullan A; Derzsi S; Hooper S; Kato T; Mansfield D; Melcher A; Harrington KJ; Sahai E
Nat Cell Biol; 2020 Jul; 22(7):758-766. PubMed ID: 32483388
[TBL] [Abstract][Full Text] [Related]
2. Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma.
Li M; Li G; Kiyokawa J; Tirmizi Z; Richardson LG; Ning J; Das S; Martuza RL; Stemmer-Rachamimov A; Rabkin SD; Wakimoto H
Acta Neuropathol Commun; 2020 Dec; 8(1):221. PubMed ID: 33308315
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus i-leader truncation bioselected against cancer-associated fibroblasts to overcome tumor stromal barriers.
Puig-Saus C; Gros A; Alemany R; Cascalló M
Mol Ther; 2012 Jan; 20(1):54-62. PubMed ID: 21863000
[TBL] [Abstract][Full Text] [Related]
4. Herpes Simplex Virus 1 Serine Protease VP24 Blocks the DNA-Sensing Signal Pathway by Abrogating Activation of Interferon Regulatory Factor 3.
Zhang D; Su C; Zheng C
J Virol; 2016 Jun; 90(12):5824-5829. PubMed ID: 27076640
[TBL] [Abstract][Full Text] [Related]
5. Noncanonical TGFβ Pathway Relieves the Blockade of IL1β/TGFβ-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal Cancer.
Guillén Díaz-Maroto N; Sanz-Pamplona R; Berdiel-Acer M; Cimas FJ; García E; Gonçalves-Ribeiro S; Albert N; Garcia-Vicién G; Capella G; Moreno V; Salazar R; Villanueva A; Molleví DG
Clin Cancer Res; 2019 Jul; 25(14):4466-4479. PubMed ID: 30979739
[TBL] [Abstract][Full Text] [Related]
6. Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager.
de Sostoa J; Fajardo CA; Moreno R; Ramos MD; Farrera-Sal M; Alemany R
J Immunother Cancer; 2019 Jan; 7(1):19. PubMed ID: 30683154
[TBL] [Abstract][Full Text] [Related]
7. Ovarian Cancer Cells Commonly Exhibit Defective STING Signaling Which Affects Sensitivity to Viral Oncolysis.
de Queiroz NMGP; Xia T; Konno H; Barber GN
Mol Cancer Res; 2019 Apr; 17(4):974-986. PubMed ID: 30587523
[TBL] [Abstract][Full Text] [Related]
8. Diminished CD68
Zhao X; Ding L; Lu Z; Huang X; Jing Y; Yang Y; Chen S; Hu Q; Ni Y
Am J Pathol; 2020 Apr; 190(4):886-899. PubMed ID: 32035062
[TBL] [Abstract][Full Text] [Related]
9. Selective Editing of Herpes Simplex Virus 1 Enables Interferon Induction and Viral Replication That Destroy Malignant Cells.
Liu X; He B
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404809
[TBL] [Abstract][Full Text] [Related]
10. Molecular Effects of Stromal-Selective Targeting by uPAR-Retargeted Oncolytic Virus in Breast Cancer.
Jing Y; Chavez V; Ban Y; Acquavella N; El-Ashry D; Pronin A; Chen X; Merchan JR
Mol Cancer Res; 2017 Oct; 15(10):1410-1420. PubMed ID: 28679779
[TBL] [Abstract][Full Text] [Related]
11. An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer.
Tsuji T; Nakamori M; Iwahashi M; Nakamura M; Ojima T; Iida T; Katsuda M; Hayata K; Ino Y; Todo T; Yamaue H
Int J Cancer; 2013 Jan; 132(2):485-94. PubMed ID: 22729516
[TBL] [Abstract][Full Text] [Related]
12. C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured Pancreatic Cancer Cells.
Morimoto D; Matsumura S; Bustos-Villalobos I; Sibal PA; Ichinose T; Naoe Y; Eissa IR; Abdelmoneim M; Mukoyama N; Miyajima N; Tanaka M; Kodera Y; Kasuya H
Cells; 2021 Jun; 10(6):. PubMed ID: 34203706
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic reovirus-mediated killing of mouse cancer-associated fibroblasts.
Kurisu N; Kaminade T; Eguchi M; Ishigami I; Mizuguchi H; Sakurai F
Int J Pharm; 2021 Dec; 610():121269. PubMed ID: 34748806
[TBL] [Abstract][Full Text] [Related]
14. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.
Wang Y; Liu T; Huang P; Zhao H; Zhang R; Ma B; Chen K; Huang F; Zhou X; Cui C; Liu X
Oncotarget; 2015 May; 6(15):13564-78. PubMed ID: 25980438
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense.
Echchgadda I; Chang TH; Sabbah A; Bakri I; Ikeno Y; Hubbard GB; Chatterjee B; Bose S
BMC Cancer; 2011 Jan; 11():43. PubMed ID: 21276246
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of tumor suppressor TSLC1 by a survivin-regulated oncolytic adenovirus significantly inhibits hepatocellular carcinoma growth.
He G; Lei W; Wang S; Xiao R; Guo K; Xia Y; Zhou X; Zhang K; Liu X; Wang Y
J Cancer Res Clin Oncol; 2012 Apr; 138(4):657-70. PubMed ID: 22237452
[TBL] [Abstract][Full Text] [Related]
17. The impact of stromal Hic-5 on the tumorigenesis of colorectal cancer through lysyl oxidase induction and stromal remodeling.
Omoto T; Kim-Kaneyama JR; Lei XF; Orimo A; Ohnishi K; Yoshihara K; Miyauchi A; Li S; Gao L; Umemoto T; Tanaka J; Nakahara K; Takeya M; Ishida F; Kudo SE; Haraguchi S; Miyazaki T; Miyazaki A
Oncogene; 2018 Mar; 37(9):1205-1219. PubMed ID: 29242607
[TBL] [Abstract][Full Text] [Related]
18. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
[TBL] [Abstract][Full Text] [Related]
19.
Jung MY; Offord CP; Ennis MK; Kemler I; Neuhauser C; Dingli D
Cancer Res; 2018 Oct; 78(20):5992-6000. PubMed ID: 30115692
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for oral squamous cell carcinoma with IAI.3B promoter-driven oncolytic adenovirus-infected carrier cells.
Zhang T; Hamada K; Hyodo M; Itoh H; Tani K; Goda H; Nakashiro K; Hamakawa H
Oncol Rep; 2011 Mar; 25(3):795-802. PubMed ID: 21206983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
